bivalent subtype c gp120
Vaccineexperimental
Clinical trial activity
5 trials · 12 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
4
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2015 (NCT02404311)
Timeline
Indications
Studied for
Mechanism of action
- Human immunodeficiency virus type I enhancer-binding protein 1Immunity, active
HIVEP1 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bivalent subtype c gp120
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03284710 | Phase 1/Phase 2 (Phase 2) | Jun 19, 2017 | Centre for the AIDS Programme of Research in South Africa, GlaxoSmithKline, HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), Sanofi-Aventis, University of Alabama, Birmingham |
| NCT03122223 | Phase 1/Phase 2 (Phase 2) | Jun 5, 2017 | GlaxoSmithKline, National Institute of Allergy and Infectious Diseases (NIAID), Sanofi-Aventis, University of California, San Francisco |
| NCT02915016 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2016 | Centre for the AIDS Programme of Research in South Africa, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02968849 | Phase 2/Phase 3 (Phase 3) | Oct 1, 2016 | Bill and Melinda Gates Foundation, GlaxoSmithKline, National Institute of Allergy and Infectious Diseases (NIAID), Sanofi, University of the Witwatersrand |
| NCT02404311 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2015 | Bill and Melinda Gates Foundation, HIV Vaccine Trials Network, Medical Research Council, National Institute of Allergy and Infectious Diseases (NIAID), Novartis, Sanofi-Aventis |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (12)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 5 | 5 | 2 | 2015 |
| GlaxoSmithKline | For profit | 3 | 0 | 2 | 2016 |
| Sanofi-Aventis | For profit | 3 | 0 | 1 | 2015 |
| Bill and Melinda Gates Foundation | Academic/Hospital | 2 | 0 | 2 | 2015 |
| Centre for the AIDS Programme of Research in South Africa | Government | 2 | 0 | 1 | 2016 |
| HIV Vaccine Trials Network | Academic/Hospital | 2 | 0 | 1 | 2015 |
| Medical Research Council | Government | 1 | 0 | 1 | 2015 |
| Novartis | For profit | 1 | 0 | 1 | 2015 |
| Sanofi | For profit | 1 | 0 | 1 | 2016 |
| University of Alabama, Birmingham | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of California, San Francisco | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of the Witwatersrand | Academic/Hospital | 1 | 0 | 1 | 2016 |
12 organizations
Page 1 / 1